Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

CUSIP: 87184Q107

Q2 2017 13F Holders as of 30 Jun 2017

Holder snapshot 6 signals
Share change
+2,708,712
SEC-reported price per share
$16.09
Number of holders
45
Value change
+$43,612,075
Number of buys
33
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
27,995,500

Security key

87184Q107

Report period

Q2 2017

Institutions

45

Top holders

10

Ownership snapshot

Top reported holders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Flagship Pioneering, LLC
Disclosed value leader
Flagship Pioneering, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2017
13F Highest disclosed value: $76,570,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Flagship Pioneering, LLC has the largest disclosed position value at $76.57M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Flagship Pioneering, LLC's linked filing trail.
Disclosed position value Top 5
Flagship Pioneering, LLC $76.57M
FMR LLC $55.9M
DEERFIELD MANAGEMENT COMPANY, L.P. $25.73M
Redmile Group, LLC $15.18M
Aisling Capital LLC $8.1M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Flagship Pioneering, LLC
13F
Company
13F
—
denominator unverified
$76,570,000
4,806,656 shares
— 31 Mar 2017
FMR LLC
13F
Company
13F
—
denominator unverified
$55,897,000
3,508,937 shares
— 31 Mar 2017
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
denominator unverified
$25,729,000
1,615,136 shares
— 31 Mar 2017
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$15,177,000
952,740 shares
— 31 Mar 2017
Aisling Capital LLC
13F
Company
13F
—
denominator unverified
$8,101,000
508,565 shares
— 31 Mar 2017
BAKER BROS. ADVISORS LP
13F
Company
13F
—
denominator unverified
$3,257,000
204,465 shares
— 31 Mar 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
45
Shares
10,799,619
Rows available
45
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders
42
Q2 2017 holders
45
Holder diff
3
Investor Q1 2017 Shares Q2 2017 Shares Share Diff Share Chg % Q1 2017 value Q2 2017 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .